Peptide ID,Peptide Name,Sequence,Sequence Length,PMID,Activity against,Molecular_Weight,Aromaticity,Instability_Index,Isoelectric_Point,Hydrophobicity,Peptide
ACP01,Anticancerous peptide 1,WKLFDDGV,8,21882228,"S. epidermitis (MIC= 60 ?M), Bacillus ubtilis (MIC= 30 ?M), P. aeruginosa (MIC= 30 ?M), E. coli (MIC= 30 ?M), Hep2 cell lines (IC50= 1.5 mM)",979.086,0.25,13.5625,4.207813453674317,-0.175,Anticancer
ACP02,TPP3,QICKAPSQTFPGLCFMDSSCRKYCIKEKFTGGHCSKLQRKCLCTKPC,47,22442231,--NA--,5305.3412,0.0851063829787234,55.90425531914892,9.202620124816896,-0.363829787,Anticancer
ACP03,Cycloviolacin-O4,GIPCGESCVWIPCISSAIGCSCKNKVCYRN,30,"16872274, 29757646, 10600388",--NA--,3191.7691000000004,0.06666666666666667,32.976666666666674,8.333779716491701,0.3533333333333334,Anticancer
ACP04,Vhl-2,GLPVCGETCFTGTCYTNGCTCDPWPVCTRN,30,15824119,Virus: HIV.,3199.6157000000003,0.1,39.209999999999994,4.370145606994629,-0.043333333,Anticancer
ACP05,citrusin I,LIATGTF,7,doi.org/10.1080/00021369.1991.10857910,--NA--,721.8412999999999,0.14285714285714288,1.9428571428571422,5.525000190734862,1.5857142857142859,Anticancer
ACP06,annosquamosin A,PMTAIVGY,8,doi.org/10.1016/S0031-9422(96)00829-1,--NA--,851.0214000000001,0.125,-36.1125,5.950042152404785,1.05,Anticancer
ACP07,glabrin B,PMVAVYGT,8,doi.org/10.1016/S0031-9422(97)00752-8,--NA--,836.9947999999999,0.125,-31.325,5.950042152404785,1.0125,Anticancer
ACP08,citrusin II,PAPFWGG,7,doi.org/10.1080/00021369.1991.10857910,--NA--,730.8099,0.28571428571428575,93.92857142857143,5.954987144470215,-0.042857143,Anticancer
ACP09,citrusin IV,PEAEWGEV,8,doi.org/10.1080/00021369.1991.10857910,--NA--,915.9426000000001,0.125,-10.7,4.0500284194946286,-0.925,Anticancer
ACP10,grifficyclocin A,PIFPPGLP,8,14598208,--NA--,837.0164,0.125,80.975,5.954987144470215,0.5374999999999999,Anticancer
ACP11,citrusin III,PLLPYGS,7,doi.org/10.1080/00021369.1991.10857910,--NA--,745.8627,0.14285714285714288,23.957142857142863,5.950042152404785,0.2714285714285715,Anticancer
ACP12,cycloleonuripeptide B,PPPYPPMIG,9,doi.org/10.1248/cpb.45.161,p-388 lymphocytic leukemia cells(IC50=6 ?M),968.1694,0.1111111111111111,78.42222222222222,5.950042152404785,-0.366666667,Anticancer
ACP13,cycloleonuripeptide A,PPPYPPMIG,9,doi.org/10.1248/cpb.45.161,--NA--,968.1694,0.1111111111111111,78.42222222222222,5.950042152404785,-0.366666667,Anticancer
ACP14,chassatide C4,GASCGETCFTGICFTAGCSCNPWPTCTRN,29,22467870,"Staphylococcus aureus (MIC: >80 ?M), Staphylococcus epidermidis (MIC: >80 ?M), Escherichia coli (MIC: >80 ?M), Human cervical carcinoma HeLa (IC50: 9.8 ?M)",2988.3582000000015,0.10344827586206896,34.265517241379314,5.962319374084472,0.1,Anticancer
ACP15,chassatide C1,GDACGETCFTGICFTAGCSCNPWPTCTRN,29,22467870,"Staphylococcus aureus (MIC: >80 ?M), Staphylococcus epidermidis (MIC: >80 ?M), Escherichia coli (MIC: >80 ?M), Human cervical carcinoma HeLa (IC50: 9.8 ?M)",3016.368300000001,0.10344827586206896,41.10344827586208,4.370145606994629,0.006896551724138029,Anticancer
ACP16,chassatide C10,GEYCGESCYLIPCFTPGCYCVSRQCVNKN,29,22467870,"Escherichia coli (MIC: >80 ?M), Staphylococcus aureus (MIC: >80 ?M), Staphylococcus epidermidis (MIC: >80 ?M), Human cervical carcinoma HeLa (IC50: 5.0 ?M)",3237.7065000000002,0.13793103448275862,32.393103448275866,6.101290702819823,-0.068965517,Anticancer
ACP17,cliotide T10,GIPCGESCVYIPCTVTALLGCSCKDKVCYKN,31,"26965458, 23419988","Human lung carcinoma A549 (IC50: 0.78 ?M), Human lung carcinoma A549/paclitaxel (IC50: 1.6 ?M), Caenorhabditis elegans",3268.8880000000004,0.06451612903225806,22.464516129032262,7.760250282287598,0.4451612903225809,Anticancer
ACP18,vibi F,GTIPCGESCVFIPCLTSALGCSCKSKVCYKN,31,18191970,--NA--,3212.824800000001,0.06451612903225806,26.070967741935487,8.325269889831542,0.5032258064516131,Anticancer
ACP19,Mela 3,GKPICGETCFKGKCYTPGCTCSYPICKKD,29,26322745,"Cancer cell lines and red blood cells/ Escherichia coli, Staphylococcus aureus, Human skin melanoma MM96L(CC50: 2.04 ?0.26 ?M), Human cervical carcinoma HeLa(CC50: 18.73 ?1.82 ?M)",3131.7108000000007,0.10344827586206896,3.0586206896551706,8.626917457580568,-0.4,Anticancer
ACP20,vitri B,GYPICGESCVGGTCNTPGCSCSWPVCTTN,29,"26399495, 20580652","U251, MDA-MB-231, A549, DU145, and BEL-7402",2897.2442,0.06896551724137931,43.07931034482759,4.0500284194946286,0.11034482758620687,Anticancer
ACP21,Glabrin A,PGLVIY,6,doi.org/10.1016/S0031-9422(97)00752-8,--NA--,660.8012,0.16666666666666669,8.333333333333334,5.950042152404785,1.5333333333333332,Anticancer
ACP22,glabrin C,PGYVLALV,8,doi.org/10.1016/S0031-9422(97)00752-8,--NA--,831.0101,0.125,-1.8625,5.950042152404785,1.8125,Anticancer
ACP23,Glabrin D,PPVYGPE,7,doi.org/10.1016/S0031-9422(97)00752-8,--NA--,757.8303999999999,0.14285714285714288,65.52857142857144,4.599831962585449,-0.828571429,Anticancer
ACP24,Mra30,GIPCGESCVFIPCLTSAIGCSCKSKVCYRN,30,"21723349, 19462049, 26399495","Human skin melanoma MM96L(IC50: 4.91 ?0.04 ?M), Human cervical carcinoma HeLa(IC50: 15.5 ?0.06 ?M), Human gastric cancer BGC-823(IC50: 1.75 ?0.05 ?M)",3139.7343,0.06666666666666667,25.083333333333336,8.333779716491701,0.5466666666666667,Anticancer
ACP25,Longicalycinin A,FYPFG,5,17604256,"Bacillus subtilis, Staphylococcus aureus, Pseudomonas aeruginosa (MIC: 12.5 ?g/ml), Escherichia coli (MIC: 12.5 ?g/ml), Candida albicans, Microsporum audouinii (MIC: 6 ?g/ml), Aspergillus niger (MIC: 12.5 ?g/ml), Trichophyton mentagrophytes (MIC: 6 ?g/ml), Dalton's lymphoma ascites(IC50: 2.62 ?M), Ehrlich's ascites carcinoma(IC50: 6.37 ?M), Megascolex konkanensis, Pontoscolex corethruses, Eudrilus eugeniae",629.7026000000001,0.6000000000000001,136.40200000000002,5.524318122863768,0.45999999999999985,Anticancer
ACP26,Cyclotide mela-6,GLPTCGETCFKGKCYTPGCSCSYPICKKD,29,26322745,"Escherichia coli, Staphylococcus aureus, Human skin melanoma MM96L(CC50: 1.58 ?0.48 ?M), Human cervical carcinoma HeLa(CC50: 11.42 ?1.00 ?M)",3090.6158000000005,0.10344827586206896,15.227586206896554,8.308830451965335,-0.317241379,Anticancer
ACP27,"Varv He, Varv peptide H",GLPVCGETCFGGTCNTPGCSCXTWPVCSRN,30,20580652,"Human glioblastoma U251-MG (IC50: 55.43 ?g/ml), Human breast adenocarcinoma MDA-MB-231 (IC50: >10 ?g/ml), Human lung carcinoma A549 (IC50: >10 ?g/ml), Human prostate cancer DU145 (IC50: >10 ?g/ml), Human hepatocarcinoma BEL-7402 (IC50: >10 ?g/ml)",2950.3531999999996,0.06896551724137931,53.57586206896552,5.962319374084472,0.09999999999999995,Anticancer
ACP28,Vitri B,GYPICGESCVGGICNIPGCSCSWPVCTTN,29,20580652,"Human glioblastoma U251-MG (IC50: 45.21 ?g/ml), Human breast adenocarcinoma MDA-MB-231 (IC50: >10 ?g/ml), Human lung carcinoma A549 (IC50: >10 ?g/ml), Human prostate cancer DU145 (IC50: >10 ?g/ml), Human hepatocarcinoma BEL-7402 (IC50: >10 ?g/ml)",2921.3516,0.06896551724137931,60.16551724137931,4.0500284194946286,0.46896551724137925,Anticancer
ACP29,White cloud bean defensin,MEKKSFAGLCFLFLVLFVAQECVLQTEAKTCENLADTFRGPCFATGNCDDHCKNKEHLLRGRCRDDFRCWCTRNC,75,16687191,"Staphylococcus aureus, Mycobacterium phlei(IC50: 86 ?6 ?M), Bacillus cereus, Bacillus megaterium(IC50: 125 ?21 ?M), Bacillus subtilis(IC50: 101 ?6 ?M), Proteus vulgaris(IC50: 68 ?8 ?M), Escherichia coli, Enterobacter aerogenes, Pseudomonas aeruginosa, Pseudomonas lachrymans, Pseudomonas fluorescens, Botrytis cinerea(IC50: 2.8 ?0.01 ?M), Botrytis cinerea(IC50: 8.6 ?0.1 ?M), Fusarium oxysporum(IC50: 2.3 ?0.02 ?M), Fusarium oxysporum(IC50: 7.8 ?0.07 ?M), Mycosphaerella arachidicola(IC50: 0.72 ?0.02 ?M), Mycosphaerella arachidicola(IC50: 1.3 ?0.04 ?M), Human breast adenocarcinoma MCF-7(IC50: 5.7 ?M), HIV-1(IC50: 120 ?M)",8658.957399999994,0.10666666666666667,31.842666666666666,7.486513710021973,-0.250666667,Anticancer
ACP30,Kalata Polypeptides K3,PICKRNGLPVCGETCTLGTCYTQGCTCSW,29,18972522,--NA--,3095.5958,0.06896551724137931,44.6793103448276,8.073778724670408,0.037931034482758606,Anticancer
ACP31,Kalata Polypeptides K1,PICTRNGLPVCGETCFGGTCNTPGCTCTW,29,18972522,--NA--,2992.433000000001,0.06896551724137931,46.35172413793104,6.240716743469237,0.11724137931034476,Anticancer
ACP32,Kalata Polypeptides K2,PVCTRNGLPVCGETCVGGTCNTPGCTCSW,29,18972522,--NA--,2916.3370000000004,0.034482758620689655,41.406896551724145,6.240716743469237,0.15172413793103437,Anticancer
ACP33,"Class I defensin, NaD2",RTCESQSHRFKGPCARDSNCATVCLTEGFSGGDCRGFRRRCFCTRPC,47,"27503651, 24015961","Fusarium oxysporum f.sp. vasinfectum(IC50: 8.3 ?2.1 ?M), Fusarium graminearum(IC50: 2 ?M), Verticillium dahliae(IC50: >10 ?M), Thielaviopsis basicola(IC50: 7 ?M), Aspergillus nidulans(IC50: 5 ?M), Puccinia coronata f.sp. avenae(IC50: 4 ?M), Puccinia sorghi(IC50: 5 ?M), Human histiocytic lymphoma U-937",5263.941599999999,0.0851063829787234,67.02765957446809,8.9862642288208,-0.691489362,Anticancer
ACP34,Linear Cyclotide Panitide L3,XAFCGETCLLGKCYTPGCSCHTGICLK,27,23195955,"Staphylococcus aureus, Candida albicans, Candida tropicalis, Escherichia coli, Human cervical carcinoma HeLa",2709.2353,0.07692307692307693,27.380769230769232,7.815647315979004,0.5230769230769229,Anticancer
ACP35,Linear Cyclotide Panitide L4,XAFCGETCLLGTCYTPGCRCTAGICLK,27,23195955,"Staphylococcus aureus, Candida albicans, Candida tropicalis, Escherichia coli, Human cervical carcinoma HeLa",2685.2138999999997,0.07692307692307693,21.00769230769231,7.8097806930542,0.6961538461538462,Anticancer
ACP36,Linear Cyclotide Panitide L7,XAFCGETCVLGTCYTPGCSCNFGICLK,27,23195955,"Escherichia coli, Staphylococcus aureus, Candida albicans, Candida tropicalis, Human cervical carcinoma HeLa(IC50: 7.7 ?M)",2691.1735000000003,0.11538461538461539,4.9192307692307695,5.997786903381347,0.7846153846153847,Anticancer
ACP37,Linear Cyclotide Panitide L8,XDCGETCVLGTCYTPGCSCSAYPLCV,26,23195955,"Escherichia coli, Staphylococcus aureus, Candida albicans, Candida tropicalis, Human cervical carcinoma HeLa",2545.9262,0.08,11.735999999999999,4.0500284194946286,0.6039999999999999,Anticancer
ACP38,Linear Cyclotide Panitide L5,XLPICGETCVLGTCYTPGCSCAYPICAR,28,23195955,"Staphylococcus aureus, Candida albicans, Candida tropicalis, Escherichia coli, Human cervical carcinoma HeLa(IC50: 10 ?M)",2795.3244999999997,0.07407407407407407,21.53333333333333,5.961125755310059,0.7370370370370372,Anticancer
ACP39,Linear Cyclotide Panitide L6,XLPICGETCVLGTCYTPGCSCAYPICVR,28,23195955,"Escherichia coli, Staphylococcus aureus, Candida albicans, Candida tropicalis, Human cervical carcinoma HeLa(IC50: 5.7 ?M)",2823.3776,0.07407407407407407,18.74074074074074,5.961125755310059,0.825925925925926,Anticancer
ACP40,"Cyclotide Cter M, Cyclotide cliotide T3",GLPTCGETCTLGTCYVPDCSCSWPICMKN,29,"25815333, 21596752, 21194241","Staphylococcus aureus (MIC: >100 ?M), Enterococcus faecalis (MIC: >100 ?M), Escherichia coli (MIC: >100 ?M), Pseudomonas aeruginosa (MIC: >100 ?M), Klebsiella pneumoniae (MIC: >100 ?M), Human cervical carcinoma HeLa (IC50: 2.0 ?M)",3083.6016,0.06896551724137931,48.53448275862069,4.370145606994629,0.21379310344827585,Anticancer
ACP41,Ep-AMP1,CVLIGQRCDNDRGPRCCSGQGNCVPLPFLGGVCAV,35,25821084,"Staphylococcus aureus (MBC: 1.25 ?M), Escherichia coli(MBC: 10 ?M), Pseudomonas aeruginosa (MBC: 80 ?M), Candida albicans (MBC: >160 ?M), Human histiocytic lymphoma U-937/GTB(IC50: >100 ?M), Staphylococcus aureus, Staphylococcus aureus, Escherichia coli, Escherichia coli, Pseudomonas aeruginosa, Pseudomonas aeruginosa, Candida albicans, Candida albicans",3608.205000000001,0.02857142857142857,20.960000000000004,7.7827039718627935,0.27999999999999997,Anticancer
ACP42,Alliumin,DDFLCAGGCL,10,15629528,"Mycosphaerella arachidicola (IC50: 1.3 ?M), Fusarium oxysporum, Bacillus cereus, Bacillus megaterium, Bacillus subtilis, Escherichia coli, Mouse lymphocytic leukemia L1210 (IC50: 8.33 ?M), Human hepatocellular carcinoma HepG2",1013.1454000000001,0.1,33.06,4.0500284194946286,0.9399999999999998,Anticancer
ACP43,Gymnin,KTCENLADDY,10,14499273,"Fusarium oxysporum(IC50: 2 ?M), Mycosphaerella arachidicola(IC50: 10 ?M), HIV-1 (IC50: 200 ?M)",1171.2345,0.1,0.5099999999999998,4.0500284194946286,-1.18,Anticancer
ACP44,Antifungal lectin PVAP,SNDIYFNFQR,10,16026901,"Mycosphaerella arachidicola(IC50: 9.8 ?M), Botrytis cinerea, Fusarium oxysporum, HIV-1, Mouse lymphocytic leukemia L1210(IC50: 3.6 ?M)",1303.3785,0.30000000000000004,-6.03,5.552794456481934,-1.05,Anticancer
ACP45,"Cyclotide cter-P, Cyclotide cliotide T4",GIPCGESCVFIPCITAAIGCSCKSKVCYRN,30,"21596752, 23419988","Staphylococcus aureus (MIC: >100 ?M), Enterococcus faecalis (MIC: >100 ?M), Escherichia coli (MIC: 1.0 ?M), Pseudomonas aeruginosa (MIC: 5.5 ?M), Klebsiella pneumoniae (MIC: 7.5 ?M), Human cervical carcinoma HeLa (IC50: 0.6 ?M), Human lung carcinoma A549 (IC50: 0.21 ?M), Human lung carcinoma A549/paclitaxel (IC50: 0.45 ?M)",3123.7349000000004,0.06666666666666667,18.663333333333334,8.333779716491701,0.6566666666666668,Anticancer
ACP46,"Cyclotide cter-R, Cyclotide cliotide T7",GIPCGESCVFIPCTVTALLGCSCKDKVCYKN,31,"23419988, 27007913, 28669767","Human lung carcinoma A549 (IC50: 0.73 ?M), Human lung carcinoma A549/paclitaxel (IC50: 1.76 ?M), Escherichia coli (MIC: 3.1 ?M), Escherichia coli (MIC: 16 ?M), Staphylococcus aureus, Escherichia coli (MBC50: 10 ?M), Escherichia coli (MBC99: 20 ?M), Escherichia coli (MIC: 40 ?M), Pseudomonas aeruginosa (MBC50: 0.313 ?M), Pseudomonas aeruginosa (MBC99: 0.629 ?M), Pseudomonas aeruginosa (MIC: 0.625 ?M), Staphylococcus aureus (MBC50: 80 ?M), Staphylococcus aureus (MBC99: 160 ?M), Staphylococcus aureus (MIC: >160 ?M), Candida albicans (MFC50: 40 ?M), Candida albicans (MFC99: 160 ?M), Candida albicans (MIC: >160 ?M), Human histiocytic lymphoma U-937/GTB (IC50: 2.8 ?M)",3252.8886000000007,0.06451612903225806,24.896774193548392,7.764683723449708,0.57741935483871,Anticancer
ACP47,"Anticancerous peptide 1, Cr-ACP1",AWKLFDDGV,9,21882228,"Staphylococcus epidermidis (MIC: 60 ?M), Bacillus subtilis (MIC: 30 ?M), Pseudomonas aeruginosa (MIC: 30 ?M), Escherichia coli (MIC: 30 ?M), Human epidermoid cancer Hep2 (IC50: 1500 ?M), Human colon adenocarcinoma HCT-15 (IC50: 1000 ?M)",1050.1638999999998,0.2222222222222222,13.166666666666666,4.207870292663575,0.04444444444444443,Anticancer
ACP48,Sesquin,KTCENLADTY,10,15949629,"Botrytis cinerea(IC50: 2.5 ?0.01 ?M), Botrytis cinerea(IC50: 9.54 ?0.11 ?M), Botrytis cinerea(IC50: 8.68 ?0.01 ?M), Fusarium oxysporum(IC50: 1.4 ?0.02 ?M), Fusarium oxysporum (IC50: 8.1 ?0.07 ?M), Fusarium oxysporum(IC50: 7.7 ?0.06 ?M ), Mycosphaerella arachidicola(IC50: 0.15 ?0.002 ?M), Mycosphaerella arachidicola(IC50: 0.54 ?0.04 ?M), Mycosphaerella arachidicola(IC50: 0.84 ?0.02 ?M), Proteus vulgaris(IC50: 75 ?6 ?M), Mycobacterium phlei (IC50: 87 ?5 ?M), Bacillus megaterium(IC50: 105 ?5 ?M), Bacillus subtilis(IC50: 98 ?2 ?M), Proteus vulgaris, Mycobacterium phlei, Bacillus megaterium, Bacillus subtilis",1157.251,0.1,-14.52,4.3702592849731445,-0.9,Anticancer
ACP49,Coccinin,KQTENLADTY,10,15572193,"Mycosphaerella arachidicola (IC50: 75 ? 5 ?M), Fusarium oxysporum (IC50: 81 ? 7 ?M), Physalospora piricola (IC50: 89 ? 4 ?M), Botrytis cinerea (IC50: 109 ? 5 ?M), Coprinus comatus (IC50: 122 ? 7 ?M), Rhizoctonia solani (IC50: 134 ? 2 ?M), HIV-1 (IC50: 41 ?M), Mouse lymphocytic leukemia L1210 (IC50: 40 ?M), Human promyelocytic leukemia HL-60 (IC50: 30 ?M)",1182.2373,0.1,28.380000000000003,4.3702592849731445,-1.5,Anticancer
ACP50,"MCoTI-II, Two inhibitor peptide topologies 2 (121-154)",GGVCPKILKKCRRDSDCPGACICRGNGYCGSGSD,34,"28669767, 11434766","Escherichia coli (MBC50: >160 ?M), Escherichia coli (MBC99: >160 ?M), Escherichia coli (MIC: >160 ?M), Pseudomonas aeruginosa (MBC50: >160 ?M), Pseudomonas aeruginosa (MBC99: >160 ?M), Pseudomonas aeruginosa (MIC: >160 ?M), Staphylococcus aureus (MBC50: >160 ?M), Staphylococcus aureus (MBC99: >160 ?M), Staphylococcus aureus (MIC: >160 ?M), Candida albicans (MFC50: >160 ?M), Candida albicans (MFC99: >160 ?M), Candida albicans (MIC: >160 ?M), Human histiocytic lymphoma U-937/GTB(IC50: >>80 ?M)",3476.9878000000003,0.029411764705882356,46.361764705882344,8.661859321594239,-0.444117647,Anticancer
ACP51,"MCoTI-I, Two inhibitor peptide topologies 1 (21-54)",GGVCPKILQRCRRDSDCPGACICRGNGYCGSGSD,34,"28669767, 16336125","Escherichia coli (MBC50: >160 ?M), Escherichia coli (MBC99: >160 ?M), Escherichia coli (MIC: >160 ?M), Pseudomonas aeruginosa (MBC50: >160 ?M), Pseudomonas aeruginosa (MBC99: >160 ?M), Pseudomonas aeruginosa (MIC: >160 ?M), Staphylococcus aureus (MBC50: >160 ?M), Staphylococcus aureus (MBC99: >160 ?M), Staphylococcus aureus (MIC: >160 ?M), Candida albicans (MFC50: >160 ?M), Candida albicans (MFC99: >160 ?M), Candida albicans (MIC: >160 ?M), Human histiocytic lymphoma U-937/GTB(IC50: >>32 ?M)",3504.9581000000007,0.029411764705882356,58.447058823529396,8.342482948303225,-0.45,Anticancer
ACP52,Mela 4,GKPICGETCFKGKCYTPGCTCSYPICKKN,29,26322745,"Escherichia coli, Staphylococcus aureus, Human skin melanoma MM96L(CC50: 2.04 ?0.26 ?M), Human cervical carcinoma HeLa(CC50: 18.73 ?1.82 ?M)/ Cancer cell lines and red blood cells",3130.7260000000006,0.10344827586206896,3.0586206896551706,8.870801353454592,-0.4,Anticancer
ACP53,Mela 2,GKPTCGETCFKGKCYTPGCTCSYPLCKKD,29,26322745,"Escherichia coli, Staphylococcus aureus, Human skin melanoma MM96L(CC50: 1.30 ?0.44 ?M), Human cervical carcinoma HeLa(CC50: 19.26 ?1.37 ?M)/ Cancer cell lines and red blood cells",3119.6571000000004,0.10344827586206896,3.0586206896551706,8.626917457580568,-0.603448276,Anticancer
ACP54,Mela 1,GKYTCGETCFKGKCYTPGCTCSYPICKKD,29,26322745,"Escherichia coli, Staphylococcus aureus, Human skin melanoma MM96L(CC50: 2.09 ?0.18 ?M), Human cervical carcinoma HeLa(CC50: 9.83 ?0.78 ?M)/ Cancer cell lines and red blood cells",3185.7151000000003,0.13793103448275862,2.7310344827586204,8.616022300720218,-0.568965517,Anticancer
ACP55,Mela 7,GLPTCGETCFKGKCYTPGCSCSYPICKKN,29,26322745,"Escherichia coli, Staphylococcus aureus, Human skin melanoma MM96L(CC50: 1.58 ?0.48 ?M), Human cervical carcinoma HeLa(CC50: 11.42 ?1.00 ?M) / Cancer cell lines and red blood cells",3089.6310000000003,0.10344827586206896,15.227586206896554,8.638199424743654,-0.317241379,Anticancer
ACP56,Mech 2,GLPTCGETCTLGKCNTPKCTCNWPICYKD,29,26322745,"Human skin melanoma MM96L(CC50: 21.94 ?1.90 ?M), Human cervical carcinoma HeLa(CC50: 36.92 ?3.25 ?M)/ Cancer cell lines and red blood cells",3150.6711000000005,0.06896551724137931,26.748275862068965,7.765081596374513,-0.355172414,Anticancer
ACP57,Mech 3,GLPTCGETCTLGKCNTPKCTCNWPICYKN,29,26322745,"Human skin melanoma MM96L(CC50: 21.94 ?1.90 ?M), Human cervical carcinoma HeLa(CC50: 36.92 ?3.25 ?M)/ Cancer cell lines and red blood cells",3149.686300000001,0.06896551724137931,26.748275862068965,8.325269889831542,-0.355172414,Anticancer
ACP58,Viphi G,GSIPCGESCVFIPCISAIIGCSCSNKVCYKN,31,21723349,"Human skin melanoma MM96L(IC50: 1.03 ?0.03 ?M), Human cervical carcinoma HeLa(IC50: 6.35 ?0.31 ?M), Human gastric cancer BGC-823(IC50: 2.91 ?0.06 ?M)",3196.7822000000006,0.06451612903225806,30.23548387096774,7.769003486633301,0.7258064516129034,Anticancer
ACP59,cliotide T2,GEFLKCGESCVQGECYTPGCSCDWPICKKN,30,"21596752, 23419988, 25815333","Staphylococcus aureus (MIC: >100 ?M), Enterococcus faecalis (MIC: >100 ?M), Escherichia coli (MIC: >100 ?M), Pseudomonas aeruginosa (MIC: >100 ?M), Klebsiella pneumoniae (MIC: >100 ?M), Human cervical carcinoma HeLa (IC50: 8.0 ?M), Human lung carcinoma A549 (IC50: 7.59 ?M), Human lung carcinoma A549/paclitaxel (IC50: 7.92 ?M)",3285.7480000000005,0.1,43.173333333333346,4.870385551452636,-0.39,Anticancer
ACP60,ChaC8,AIPCGESCVWIPCISTVIGCSCSNKVCYR,29,22467870,"Escherichia coli (MIC: 6.6 ?M), Staphylococcus aureus (MIC: >80 ?M), Staphylococcus epidermidis (MIC: >80 ?M), Human cervical carcinoma HeLa (IC50: 1.0 ?M)",3092.6778000000004,0.06896551724137931,25.800000000000004,7.8097806930542,0.7551724137931034,Anticancer
ACP61,Viphi D,GIPCGESCVFIPCISSVIGCSCSSKVCYRN,30,21723349,"Human skin melanoma MM96L(IC50: 2.51 ?0.03 ?M), Human cervical carcinoma HeLa(IC50: 5.24 ?0.40 ?M), Human gastric cancer BGC-823; Human foreskin fibroblasts HFF-1(IC50: 1.55 ?0.09 ?M)",3112.6657999999998,0.06666666666666667,31.503333333333337,7.773550605773925,0.75,Anticancer
ACP62,Vaby A,GLPVCGETCAGGTCNTPGCSCSWPICTRN,29,"21434649, 20558471","Human histiocytic lymphoma U-937/GTB(IC50: 7.6 ?M), Salmonella enterica serovar Typhimurium (MIC: 90 ?M), Escherichia coli (MIC: 32.5 ?M), Staphylococcus aureus (MIC: >90 ?M)",2888.2839000000004,0.034482758620689655,45.47586206896552,5.962319374084472,0.07586206896551721,Anticancer
ACP63,Viphi E,GSIPCGESCVFIPCISAVIGCSCSNKVCYKN,31,21723349,"Human skin melanoma MM96L(IC50: 2.51 ?0.03 ?M), Human cervical carcinoma HeLa(IC50: 5.24 ?0.40 ?M), Human gastric cancer BGC-823; Human foreskin fibroblasts HFF-1(IC50: 1.55 ?0.09 ?M);",3182.7556000000004,0.06451612903225806,30.23548387096774,7.769003486633301,0.7161290322580645,Anticancer
ACP64,"Cyclotide chassatide C11, Uncyclotide ChaC11",IPCGESCVWIPCISGMFGCSCKDKVCYS,28,22467870,"Escherichia coli (MIC: 8.5 ?M), Staphylococcus aureus (MIC: >80 ?M), Staphylococcus epidermidis (MIC: >80 ?M), Human cervical carcinoma HeLa (IC50: 1.2 ?M)",3016.5999,0.10714285714285715,20.914285714285715,6.0287073135375975,0.6071428571428571,Anticancer
ACP65,"Cyclotide chassatide C7, Uncyclotide ChaC7",IPCGESCVWIPCITAIAGCSCKNKVCYT,28,22467870,"Escherichia coli (MIC: 6.4 ?M), Staphylococcus aureus (MIC: >80 ?M), Staphylococcus epidermidis (MIC: >80 ?M), Human cervical carcinoma HeLa (IC50: 1.2 ?M)",2963.5606000000007,0.07142857142857144,29.371428571428574,7.769003486633301,0.7500000000000001,Anticancer
ACP66,Cliotide T1,GIPCGESCVFIPCITGAIGCSCKSKVCYRN,30,"26668107, 21596752, 25815333","Staphylococcus aureus (MIC: >100 ?M), Enterococcus faecalis (MIC: >100 ?M), Escherichia coli (MIC: 1.1 ?M), Pseudomonas aeruginosa (MIC: 2.7 ?M), Klebsiella pneumoniae (MIC: 4.7 ?M), Human cervical carcinoma HeLa (IC50: 0.6 ?M)",3109.7083000000002,0.06666666666666667,13.003333333333334,8.333779716491701,0.5833333333333336,Anticancer
ACP67,Viphi F,GSIPCGESCVFIPCISAIIGCSCSSKVCYKN,31,"21723349, 25815333","Human skin melanoma MM96L(IC50: 1.03 ?0.03 ?M), Human cervical carcinoma HeLa(IC50: 6.35 ?0.31 ?M), Human gastric cancer BGC-823(IC50: 2.91 ?0.06 ?M); Human foreskin fibroblasts HFF-1(IC50: 1.76 ?0.12 ?M)",3169.7569000000003,0.06451612903225806,28.809677419354845,7.769003486633301,0.8129032258064519,Anticancer
ACP68,Viphi A,GSIPCGESCVFIPCISSVIGCACKSKVCYKN,31,"21723349, 25815333","Human skin melanoma MM96L(IC50: 4.91 ?0.04 ?M), Human cervical carcinoma HeLa(IC50: 15.5 ?0.06 ?M), Human gastric cancer BGC-823(IC50: 1.75 ?0.05 ?M); Human foreskin fibroblasts HFF-1(IC50: 3.19 ?0.01 ?M)",3196.8253000000004,0.06451612903225806,32.46774193548387,8.325269889831542,0.7032258064516129,Anticancer
ACP69,Cyclosaplin,RLGDGCTR,8,24503375,Human breast adenocarcinoma MDA-MB-231(IC50: 2.06 ?g/ml),876.9811,0,49.5,8.249519538879394,-0.9625,Anticancer
ACP70,Vibi G,GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN,31,18191970,Human histiocytic lymphoma U-937/GTB (IC50: 0.96 ?0.1 ?M),3246.841000000001,0.0967741935483871,37.19354838709678,8.325269889831542,0.4709677419354839,Anticancer
ACP71,Psyle C,KLCGETCFKFKCYTPGCSCSYPFCK,25,20575512,Human histiocytic lymphoma U-937/GTB(IC50: 3.50 ?M),2844.3967000000002,0.2,13.448,8.638199424743654,-0.06,Anticancer
ACP72,Cter G,GLPCGESCVFIPCITTVVGCSCKNKVCYNN,30,"28669767, 21194241","Escherichia coli (MBC50: 10 ?M), Escherichia coli (MBC99: 20 ?M), Escherichia coli (MIC: 40 ?M), Escherichia coli (MIC: >160 ?M), Escherichia coli (MIC: >160 ?M), Escherichia coli (MIC: >160 ?M), Pseudomonas aeruginosa (MBC50: 0.313 ?M), Pseudomonas aeruginosa (MBC99: 0.625 ?M), Pseudomonas aeruginosa (MIC: 0.625 ?M), Pseudomonas aeruginosa (MIC: 160 ?M), Pseudomonas aeruginosa (MIC: 160 ?M), Staphylococcus aureus (MBC50: 40 ?M), Staphylococcus aureus (MBC99: 160 ?M), Staphylococcus aureus (MIC: >160 ?M), Candida albicans (MFC50: 40 ?M), Candida albicans (MFC99: 80 ?M), Candida albicans (MIC: 160 ?M), Human histiocytic lymphoma U-937/GTB(IC50: 3.0 ?M)",3152.7296000000006,0.06666666666666667,35.46,7.769003486633301,0.5633333333333334,Anticancer
ACP73,Vitri C,GLPICGETCVGGTCNTPGCFCTWPVCTRN,29,"20580652, 26399495, 20580653","Human glioblastoma U251-MG (IC50: 46.96 ?g/ml), Human breast adenocarcinoma MDA-MB-231 (IC50: >10 ?g/ml), Human lung carcinoma A549 (IC50: >10 ?g/ml), Human prostate cancer DU145 (IC50: >10 ?g/ml), Human hepatocarcinoma BEL-7402 (IC50: >10 ?g/ml)",2990.4601000000002,0.06896551724137931,34.76551724137932,5.962319374084472,0.28620689655172415,Anticancer
ACP74,Vitri D,GLPVCGETCFTGSCYTPGCSCNWPVCNRN,29,"20580652, 26399495, 20580654","Human glioblastoma U251-MG (IC50: 51.65 ?g/ml), Human breast adenocarcinoma MDA-MB-231 (IC50: >10 ?g/ml), Human lung carcinoma A549 (IC50: >10 ?g/ml), Human prostate cancer DU145 (IC50: >10 ?g/ml), Human hepatocarcinoma BEL-7402 (IC50: >10 ?g/ml)",3069.4737999999998,0.10344827586206896,44.28620689655172,5.9617509841918945,-0.027586207,Anticancer
ACP75,Vitri E,GLPVCGETCVGGTCNTPGCSCSWPVCFRN,29,"26399495, 20580652","Human glioblastoma U251-MG (IC50: 54.39 ?g/ml), Human breast adenocarcinoma MDA-MB-231 (IC50: >10 ?g/ml), Human lung carcinoma A549 (IC50: >10 ?g/ml), Human prostate cancer DU145 (IC50: >10 ?g/ml), Human hepatocarcinoma BEL-7402 (IC50: >10 ?g/ml)",2948.3803,0.06896551724137931,35.34827586206897,5.962319374084472,0.26896551724137924,Anticancer
ACP76,"Vitri F, Cycloviolacin-O19",GTLPCGESCVWIPCISSVVGCACKSKVCYKD,31,"26399495, 20580656, 20580652","Human glioblastoma U251-MG (IC50: 6.31 ?g/ml), Human breast adenocarcinoma MDA-MB-231 (IC50: 2.74 ?g/ml), Human lung carcinoma A549 (IC50: 3.58 ?g/ml), Human prostate cancer DU145 (IC50: 3.44 ?g/ml), Human hepatocarcinoma BEL-7402 (IC50: 5.36 ?g/ml)",3236.8462,0.06451612903225806,34.13225806451614,7.765081596374513,0.5548387096774194,Anticancer
ACP77,vibi E,GIPCAESCVWIPCTVTALIGCGCSNKVCYN,30,18191970,Human histiocytic lymphoma U-937/GTB (IC50: 3.2 ?0.8 ?M),3105.6732,0.06666666666666667,27.763333333333335,5.961125755310059,0.8166666666666668,Anticancer
ACP78,Vibi H,GLLPCAESCVYIPCLTTVIGCSCKSKVCYKN,31,18191970,Human histiocytic lymphoma U-937/GTB (IC50: 1.6 ?0.2 ?M),3296.984200000001,0.06451612903225806,35.95161290322581,8.316888999938964,0.6677419354838711,Anticancer
ACP79,Vitri peptide A,GIPCGESCVWIPCITSAIGCSCKSKVCYRN,30,"20580652, 14987049, 18191970","Human glioblastoma U251-MG (IC50: 6.03 ?g/ml), Human breast adenocarcinoma MDA-MB-231 (IC50: 3.69 ?g/ml), Human lung carcinoma A549 (IC50: 3.90 ?g/ml), Human prostate cancer DU145 (IC50: 3.07 ?g/ml), Human hepatocarcinoma BEL-7402 (IC50: 4.94 ?g/ml), Human histiocytic lymphoma U-937/GTB (IC50: 0.6 ?M), Human Myeloma cells RPMI-8226/s (IC50: 1 ?M)",3178.7704000000003,0.06666666666666667,18.663333333333334,8.333779716491701,0.4466666666666667,Anticancer
ACP80,Vibi D,GLPVCGETCFGGRCNTPGCTCSYPICTRN,29,18191970,Human histiocytic lymphoma U-937/GTB (IC50: >30 ?M),3010.4515,0.06896551724137931,52.65862068965518,7.77812671661377,-0.031034483,Anticancer
ACP81,Tricyclon-A,GGTIFDCGESCFLGTCYTKGCSCGEWKLCYGTN,33,"28669767, 26399495, 15893660","Escherichia coli (MBC50: 40 ?M), Escherichia coli (MBC99: 40 ?M), Escherichia coli (MIC: 160 ?M), Pseudomonas aeruginosa (MBC50: 40 ?M), Pseudomonas aeruginosa (MBC99: 40 ?M), Pseudomonas aeruginosa (MIC: 80 ?M), Staphylococcus aureus (MBC50: 80 ?M), Staphylococcus aureus (MBC99: 80 ?M), Staphylococcus aureus (MIC: 160 ?M), Candida albicans (MFC50: 40 ?M), Candida albicans (MFC99: 40 ?M), Candida albicans (MIC: 80 ?M), Human histiocytic lymphoma U-937/GTB(IC50: 8.7 ?M)",3504.941300000001,0.15151515151515152,11.081818181818175,4.678951835632325,0.006060606060606039,Anticancer
ACP82,"Cyclotide cter-B, Cyclotide cliotide T10",GVPCAESCVWIPCTVTALLGCSCKDKVCYLN,31,"23419988, 28669767, 21194241, 21596752","Human lung carcinoma A549 (IC50: 0.70 ?M), Human lung carcinoma A549/paclitaxel (IC50: 2.53 ?M), Escherichia coli (MBC50: 80 ?M), Escherichia coli (MBC99: 160 ?M), Escherichia coli (MIC: >160 ?M), Pseudomonas aeruginosa (MBC50: 1.25 ?M), Pseudomonas aeruginosa (MBC99: 5 ?M), Pseudomonas aeruginosa (MIC: 20 ?M), Staphylococcus aureus (MBC50: 160 ?M), Staphylococcus aureus (MBC99: >160 ?M), Staphylococcus aureus (MIC: >160 ?M), Candida albicans (MFC50: >160 ?M), Candida albicans (MFC99: >160 ?M), Candida albicans (MIC: >160 ?M), Human histiocytic lymphoma U-937/GTB (IC50: 3.5 ?M)",3276.9100000000003,0.06451612903225806,37.20967741935485,6.0287073135375975,0.7677419354838713,Anticancer
ACP83,Viba 15,GLPVCGETCVGGTCNTPGCACSWPVCTRN,29,"21723349, 25815333, 26399495","Human skin melanomaMM96L(IC50: 3.10 ?0.06 ?M), Human cervical carcinoma HeLa(IC50: 10.21 ?0.43 ?M), Human gastric cancer BGC-823(IC50: 1.32 ?0.15 ?M)",2886.3109999999997,0.034482758620689655,50.50000000000001,5.962319374084472,0.23793103448275857,Anticancer
ACP84,Cyclopeptide E,PGLGFY,6,16040066,Human nasopharyngeal carcinoma (IC50: 0.017 ?M),652.7377,0.33333333333333337,62.66833333333334,5.950042152404785,0.4833333333333332,Anticancer
ACP85,Cyclopeptide F,PGMGIYLPM,9,16040066,Human nasopharyngeal carcinoma (IC50: 0.06 ?M),978.2286999999999,0.1111111111111111,12.477777777777783,5.950042152404785,0.7555555555555556,Anticancer
ACP86,Flower-specific defensin / NaD1,RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,47,"12644678, 23689717, 24015961, 27503651","Cryptococcus neoformans var. grubii (IC50: 2.04 ?0.15 ?M), Cryptococcus neoformans var. neoformans (IC50: 0.91 ?0.81 ?M), Cryptococcus neoformans var. neoformans (IC50: 2.38 ?1.01 ?M), Cryptococcus gattii (IC50: 1.45 ?0.59 ?M), Cryptococcus gattii (IC50: 1.57 ?0.57 ?M), Aspergillus niger (IC50: 2.1 ?0.76 ?M), Aspergillus flavus (IC50: >10 ?M), Candida albicans (IC50: 2.3 ?0.6 ?M), Verticillium dahliae (IC50: 0.75 ?M), Thielaviopsis basicola (IC50: 1 ?M), Aspergillus nidulans (IC50: 0.8 ?M), Puccinia coronata f.sp. avenae (IC50: 2.5 ?M), Puccinia sorghi (IC50: 2 ?M), Fusarium oxysporum f.sp. vasinfectum (IC50: 1.5 ?0.25 ?M), Fusarium graminearum (IC50: 0.4 ?0.3 ?M), Colletotrichum graminicola (IC50: 4.4 ?0.1 ?M), Aspergillus parasiticus (IC50: 4.5 ?0.27 ?M)",5304.292299999999,0.0425531914893617,71.18085106382978,9.081741905212404,-0.472340426,Anticancer
ACP87,Kalata B2,GLPVCGETCFGGTCNTPGCSCTWPICTRD,29,"20564013, 15654741, 28669767, 18618891, 18426225, 18557620, 17534989, 10600388, 11535828","Escherichia coli (MBC50: 160 ?M), Escherichia coli (MBC99: >160 ?M), Escherichia coli (MIC: >160 ?M), Pseudomonas aeruginosa (MBC50: 40 ?M), Pseudomonas aeruginosa (MBC99: 80 ?M), Pseudomonas aeruginosa (MIC: 160 ?M), Staphylococcus aureus (MBC50: >160 ?M), Staphylococcus aureus (MBC99: >160 ?M), Staphylococcus aureus (MIC: >160 ?M), Candida albicans (MBC50: >160 ?M), Candida albicans (MBC99: >160 ?M), Candida albicans (MIC: >160 ?M), Human histiocytic lymphoma U-937/GTB(IC50: 2.6 ?M)",2979.3912,0.06896551724137931,47.279310344827586,4.669346046447754,0.11379310344827583,Anticancer
ACP88,Varv peptide D,GLPICGETCVGGSCNTPGCSCSWPVCTRN,29,"20580652, 10075760, 26399495","Human glioblastoma U251-MG (IC50: 46.62 ?g/ml), Human breast adenocarcinoma MDA-MB-231 (IC50: >10 ?g/ml), Human lung carcinoma A549 (IC50: >10 ?g/ml), Human prostate cancer DU145 (IC50: >10 ?g/ml), Human hepatocarcinoma BEL-7402 (IC50: >10 ?g/ml)",2902.3103999999994,0.034482758620689655,54.11724137931036,5.962319374084472,0.15517241379310331,Anticancer
ACP89,Varv peptide H,GLPVCGETCFGGTCNTPGCSCETWPVCSRN,30,"20580652, 10075760, 26399495","Human glioblastoma U251-MG (IC50: 44.70 ?g/ml), Human breast adenocarcinoma MDA-MB-231 (IC50: >10 ?g/ml), Human lung carcinoma A549 (IC50: >10 ?g/ml), Human prostate cancer DU145 (IC50: >10 ?g/ml), Human hepatocarcinoma BEL-7402 (IC50: >10 ?g/ml)",3079.4672,0.06666666666666667,41.25666666666667,4.531227302551269,-0.02,Anticancer
ACP90,Kalata B7,GLPVCGETCTLGTCYTQGCTCSWPICKRN,29,"28669767, 20564013, 11535828, 17534989, 18618891, 18557620, 18295894, 18426225","Escherichia coli (MBC50: 20 ?M), Escherichia coli (MBC99: 40 ?M), Escherichia coli (MIC: 160 ?M), Escherichia coli (MIC: >160 ?M), Escherichia coli (MIC: >160 ?M), Escherichia coli (MIC: >160 ?M), Pseudomonas aeruginosa (MBC50: 0.313 ?M), Pseudomonas aeruginosa (MBC99: 0.625 ?M), Pseudomonas aeruginosa (MIC: 1.25 ?M), Pseudomonas aeruginosa (MIC: 160 ?M), Pseudomonas aeruginosa (MIC: 160 ?M), Staphylococcus aureus (MBC50: 80 ?M), Staphylococcus aureus (MBC99: 160 ?M), Staphylococcus aureus (MIC: >160 ?M), Candida albicans (MFC50: 40 ?M), Candida albicans (MFC99: 160 ?M), Candida albicans (MIC: >160 ?M), Human histiocytic lymphoma U-937/GTB(IC50: 29 ?M)",3095.5958,0.06896551724137931,49.86206896551725,7.773550605773925,0.037931034482758606,Anticancer
ACP91,Varv peptide E (Cycloviolacin-O12),GLPICGETCVGGTCNTPGCSCSWPVCTRN,29,"20580652, 14987049, 10075760, 18618891, 18081258","Human glioblastoma U251-MG (IC50: 38.84 ?g/ml), Human breast adenocarcinoma MDA-MB-231 (IC50: >10 ?g/ml), Human lung carcinoma A549 (IC50: >10 ?g/ml), Human prostate cancer DU145 (IC50: >10 ?g/ml), Human hepatocarcinoma BEL-7402 (IC50: >10 ?g/ml), Human histiocytic lymphoma U-937/GTB (IC50: 4 ?M), Human Myeloma cells RPMI-8226/s (IC50: 4 ?M)",2916.3369999999995,0.034482758620689655,39.948275862068975,5.962319374084472,0.15862068965517234,Anticancer
ACP92,Kalata-B1,GLPVCGETCVGGTCNTPGCTCSWPVCTRN,29,"21928440, 10430870, 21723349, 21576247, 28669767, 11535828, 7703226, 10430870, 11888199, 12482862, 12482868, 12779323, 17534989","Escherichia coli (MIC: >500 ?M), Pseudomonas aeruginosa (MIC: >500 ?M), Proteus vulgaris (MIC: >500 ?M), Klebsiella oxytoca (MIC: 54.8 ?M), Staphylococcus aureus (MIC: 0.26 ?M), Micrococcus luteus (MIC: 40.4 ?M), Candida albicans (MIC: >500 ?M), Candida kefyr (MIC: 21.4 ?M), Candida tropicalis (MIC: >500 ?M), Human skin melanoma MM96L(IC50: 3.10 ?0.06 ?M), Human cervical carcinoma HeLa(IC50: 10.21 ?0.43 ?M), Human gastric cancer BGC-823(IC50: 1.32 ?0.15 ?M), Escherichia coli (MBC50: 40 ?M), Escherichia coli (MBC99: 80 ?M), Escherichia coli (MIC: >160 ?M), Pseudomonas aeruginosa (MBC50: 2.5 ?M), Pseudomonas aeruginosa (MBC99: 10 ?M), Pseudomonas aeruginosa (MIC: 40 ?M), Pseudomonas aeruginosa (MIC: >160 ?M), Staphylococcus aureus (MBC50: 160 ?M), Staphylococcus aureus (MBC99: >160 ?M), Staphylococcus aureus (MIC: >160 ?M), Candida albicans (MFC50: >160 ?M), Candida albicans (MFC99: >160 ?M), Candida albicans (MIC: >160 ?M), Human histiocytic lymphoma U-937/GTB(IC50: 6.9 ?M )",2916.3370000000004,0.034482758620689655,46.5896551724138,5.962319374084472,0.15172413793103443,Anticancer
ACP93,Kalata-B13,GLPVCGETCFGGTCNTPGCACDPWPVCTRD,30,"28669767, 17534989","Escherichia coli (MBC50: 40 ?M), Escherichia coli (MBC99: 80 ?M), Escherichia coli (MIC: >160 ?M), Pseudomonas aeruginosa (MBC50: 5 ?M), Pseudomonas aeruginosa (MBC99: 10 ?M), Pseudomonas aeruginosa (MIC: 20 ?M), Staphylococcus aureus (MBC50: >160 ?M), Staphylococcus aureus (MBC99: >160 ?M), Staphylococcus aureus (MIC: >160 ?M), Candida albicans (MFC50: >160 ?M), Candida albicans (MFC99: >160 ?M), Candida albicans (MIC: >160 ?M), Human histiocytic lymphoma U-937/GTB(IC50: 3.8 ?M)",3060.4638999999997,0.06666666666666667,55.84,4.274315071105957,0.03999999999999997,Anticancer
ACP94,Ligatoxin-B,KSCCPSTTARNIYNTCRLTGASRSVCASLSGCKIISGSTCDSGWNH,46,"12049612, 25815333","Human histiocytic lymphoma U-937/GTB (IC50: 1.8 ?M), Human renal adenocarcinoma ACHN (IC50: 3.2 ?M)",4798.380299999999,0.043478260869565216,57.57391304347826,8.940040397644044,-0.193478261,Anticancer
ACP95,Cycloviolacin-O3,GIPCGESCVWIPCLTSAIGCSCKSKVCYRN,30,"28669767, 10600388, 16872274","Escherichia coli (MBC50: 5 ?M), Escherichia coli (MBC99: 10 ?M), Escherichia coli (MIC: 10 ?M), Pseudomonas aeruginosa (MBC50: 5 ?M), Pseudomonas aeruginosa (MBC99: 5 ?M), Pseudomonas aeruginosa (MIC: 10 ?M), Staphylococcus aureus (MBC50: 5 ?M), Staphylococcus aureus (MBC99: 10 ?M), Staphylococcus aureus (MIC: 20 ?M), Candida albicans (MFC50: 10 ?M), Candida albicans (MIC: 20 ?M), Candida albicans (MFC99: 10 ?M), Human histiocytic lymphoma U-937/GTB(IC50: 0.42 ?M)",3178.7704000000003,0.06666666666666667,25.083333333333336,8.333779716491701,0.42333333333333345,Anticancer
ACP96,Cycloviolacin-O2,GIPCGESCVWIPCISSAIGCSCKSKVCYRN,30,"12477048, 6872274, 20580652, 21723349, 28669767","Human Myeloma cells RPMI-8226/s (IC50: 0.12 ?M), Human Myeloma cells RPMI-8226/Dox40 (IC50: 0.12 ?M), Human Myeloma cells RPMI-8226/LR-5 (IC50: 0.12 ?M), Human histiocytic lymphoma U-937/GTB (IC50: 0.26 ?M), Human histiocytic lymphoma U-937-Vcr (IC50: 0.20 ?M), Human renal adenocarcinoma ACHN (IC50: 0.22 ?M), Human lymphoblastic leukemia CCRF-CEM (IC50: 0.11 ?M), Human lymphoblastic leukemia CCRF-CEM/VM-1 (IC50: 0.14 ?M), Human lung carcinoma NCI-H69 (IC50: 0.12 ?M), Human lung carcinoma NCI-H69AR (IC50: 0.26 ?M), Chronic lymphocytic leukemia (IC50: 0.10 ?M), Ovarian carcinoma (IC50: 1.32 ?M), Human glioblastoma U251-MG (IC50: 17.05 ?g/ml), Human breast adenocarcinoma MDA-MB-231 (IC50: 4.81 ?g/ml), Human lung carcinoma A549 (IC50: 5.99 ?g/ml), Human prostate cancer DU145 (IC50: 5.08 ?g/ml), Human hepatocarcinoma BEL-7402 (IC50: 6.07 ?g/ml), Human skin melanoma MM96L (IC50: 0.65 ?0.06 ?M), Human cervical carcinoma HeLa (IC50: 3.43 ?0.15 ?M), Human gastric cancer BGC-823 (IC50: 4.81 ?0.48 ?M), Escherichia coli (MBC50: 5 ?M), Escherichia coli (MBC99: 10 ?M), Escherichia coli (MIC: 20 ?M), Escherichia coli (MIC: 160 ?M), Escherichia coli (MIC: 160 ?M), Escherichia coli (MIC: 80 ?M), Pseudomonas aeruginosa (MBC50: 5 ?M), Pseudomonas aeruginosa (MBC99: 5 ?M), Pseudomonas aeruginosa (MIC: 10 ?M), Pseudomonas aeruginosa (MIC: 80 ?M), Pseudomonas aeruginosa (MIC: 160 ?M), Staphylococcus aureus (MBC50: 10 ?M), Staphylococcus aureus (MBC99: 20 ?M), Staphylococcus aureus (MIC: 20 ?M), Candida albicans (MFC50: 10 ?M), Candida albicans (MFC99: 10 ?M), Candida albicans (MIC: 20 ?M)",3164.7438,0.06666666666666667,25.083333333333336,8.333779716491701,0.44333333333333336,Anticancer
ACP97,Cyclotide varv Hm,CLPVCGETCFGGTCNTPGCSCETWPVCSRN,30,20580652,--NA--,3125.5588,0.06666666666666667,47.67666666666666,4.531227302551269,0.07666666666666658,Anticancer
ACP98,anticancer peptide from algae protein waste (Chlorella vulgaris); Antioxidative peptide derived from algae protein waste (Chlorella vulgaris),VECYGPNRPQF,11,"23271625, 19916544",Angiotensin Converting Enzyme(IC50= 29.6 ?M),1309.4493999999997,0.18181818181818182,69.48181818181817,5.965331840515137,-0.945454545,Anticancer
ACP99,Cancer cell proliferation inhibitor,EQRPR,5,20594954,--NA--,684.7451,0,69.96000000000001,9.698510932922364,-3.52,Anticancer
ACP100,DC1,GAFLKCGESCVYLPCLTTVVGCSCQNSVCYRD,32,--NA--,--NA--,3419.9675999999995,0.09375,23.09375,6.151309013366698,0.50625,Anticancer
ACP101,DC2,GAVPCGETCVYLPCITPDIGCSCQNKVCYRD,31,--NA--,--NA--,3308.826,0.06451612903225806,12.299999999999999,4.780579948425292,0.1774193548387097,Anticancer
ACP102,ChaC2,GIPCAESCVWIPPCTITALMGCSCKNNVCYNN,32,--NA--,--NA--,3406.0073000000007,0.0625,40.76562500000001,5.961125755310059,0.4375,Anticancer
ACP103,Cliotide T19,GSVIKCGESCLLGKCYTPGCTCSRPICKKD,30,--NA--,--NA--,3150.7589000000007,0.03333333333333333,46.07666666666667,8.649868202209475,-0.04,Anticancer
ACP104,DC3,GTSCGETCVLLPCLSSVLGCTCQNKRCYKD,30,--NA--,--NA--,3182.7145,0.03333333333333333,56.53666666666666,7.769515037536622,0.12333333333333331,Anticancer
ACP105,Viscotoxin B2,KSCCKNTTGRNIYNTCRFAGGSRERCAKLSGCKIISASTCPSYPDK,46,15700822,--NA--,4977.6855,0.06521739130434782,34.31739130434783,9.455851936340334,-0.641304348,Anticancer
ACP106,Viscotoxin A2,KSCCPNTTGRNIYNTCRFGGGSRQVCASLSGCKIISASTCPSDYPK,46,--NA--,--NA--,4833.4673,0.06521739130434782,49.065217391304344,9.125451469421389,-0.382608696,Anticancer
ACP107,Viscotoxin A1,KSCCPNTTGRNIYNTCRLTGSSRETCAKLSGCKIISASTCPSNYPK,46,--NA--,--NA--,4916.5976,0.043478260869565216,41.64782608695652,9.302932929992675,-0.55,Anticancer
ACP108,Vigno 5,GLPLCGETCVGGTCNTPGCSCGWPVCVRN,29,"22890611, 26751970, 26399495",Human cervical carcinoma HeLa at 10 ?M,2884.3381,0.034482758620689655,30.36206896551725,5.962319374084472,0.3172413793103448,Anticancer
ACP109,"Antitumour cyclic pentapeptide, Astin A",PTSFT,5,--NA--,--NA--,551.5894000000001,0.2,8,5.954987144470215,-0.2,Anticancer
ACP110,Lunasin,SKWQHQQDSCRKQLQGVNLTPCEKHIMQKIQGRGDDDDDDDDD,43,18211015,--NA--,5027.330200000004,0.023255813953488372,46.627906976744185,4.599945640563964,-1.762790698,Anticancer
ACP111,Lunasin [25-29],HIMQK,5,18211015,--NA--,655.8096999999999,0,80.8,8.757208061218265,-0.84,Anticancer
ACP112,Soymetide,MITLAIPVNKPGR,13,"12681509, 6298713, 29287362",--NA--,1409.7391999999998,0,34.24615384615385,11.000256538391113,0.3461538461538463,Anticancer
ACP113,Cycloviolacin O2,CGESCVWIPCISSAIGCSCKSKVCYRNGIP,30,--NA--,--NA--,3164.743800000001,0.06666666666666667,22.586666666666673,8.333779716491701,0.44333333333333336,Anticancer
ACP114,--NA--,AEINMPNY,8,29287362,--NA--,951.0544,0.125,87.75,4.0500284194946286,-0.65,Anticancer
ACP115,--NA--,GEGSGA,6,29287362,--NA--,476.4384,0,-18.38333333,4.0500284194946286,-0.616666667,Anticancer
ACP116,Cycloviolacin O2 (CyO2),GIACGESCVWIPCISSAIGCSCVKSKCYRN,30,20564026,"MCF-7 (IC50= 3.17 ?M), MCF-7/ADR (IC50= 3.27 ?M)",3138.7065000000002,0.06666666666666667,42.56000000000001,8.333779716491701,0.5566666666666668,Anticancer
ACP117,Cliotide T4,GIPCGESCVYIPCITAAIGCSCKSKVCYRN,30,25815333,HeLa and human erythrocytes,3139.7343,0.06666666666666667,16.15,8.325205421447755,0.52,Anticancer
ACP118,Varv A,GLPCVGETCVGGTCNTPGCSCSWPVCTRN,29,25815333,10 cancer cell lines,2902.3104000000003,0.034482758620689655,31.820689655172416,5.962319374084472,0.14827586206896542,Anticancer
ACP119,--NA--,GLTSK,5,29287362,--NA--,504.57770000000005,0,8,8.750052070617677,-0.4,Anticancer
ACP120,--NA--,HCQRPA,6,29287362,--NA--,710.8054999999999,0,59.966666666666676,8.258609580993653,-1.416666667,Anticancer
ACP121,--NA--,IQQGN,5,29287362,--NA--,558.5852,0,29.540000000000003,5.525000190734862,-1.28,Anticancer
ACP122,psyle C,KLCGETCFKFKCYTPGCSCSCSYPFCK,27,20564026,"MCF-7 (IC50= 2.98 ?M), MCF-7/ADR (IC50= 8.7 ?M)",3034.6169,0.18518518518518517,25.266666666666666,8.561417579650882,0.007407407407407397,Anticancer
ACP123,Phoratoxins B,KSCCPTTTARNIYNTCRFGGGSRPICAKLSGCKIISGTKCDSNGWDH,47,25815333,Mice,5009.6858,0.06382978723404255,46.640425531914886,9.125580406188966,-0.465957447,Anticancer
ACP124,Phoratoxins C,KSCCPTTTARNIYNTCRFGGGSRPICAKLSGCKIISGTKCDSNGWTH,47,25815333,10 cancer cell lines (IC50= 0.16 ?M),4995.7023,0.06382978723404255,43.44255319148935,9.33845500946045,-0.406382979,Anticancer
ACP125,Phoratoxins E,KSCCPTTTARNIYNTCRFGGGSRPVCAKLSGCKIISGTKCDSGHDH,46,25815333,10 cancer cell lines,4832.486,0.043478260869565216,52.2086956521739,9.125773811340334,-0.456521739,Anticancer
ACP126,Phoratoxins A,KSCCPTTTARNIYNTCRFGGGSRPVCAKLSGCKIISGTKCDSNGHNH,47,25815333,Mice,4945.6038,0.0425531914893617,53.151063829787226,9.338583946228027,-0.521276596,Anticancer
ACP127,Limyin,KTCENLATYYRGPCF,15,23412850,--NA--,1766.0057000000002,0.2,-4.4,8.033034706115721,-0.533333333,Anticancer
ACP128,Gynurin,LNCCNLLL,8,doi.org/10.1007/s10989-018-9726-5,--NA--,905.1367,0,5.15,5.5114156723022445,1.65,Anticancer
ACP129,--NA--,LSGNK,5,29287362,--NA--,517.5763999999999,0,38.379999999999995,8.750052070617677,-0.96,Anticancer
ACP130,--NA--,MPACGSS,7,29287362,--NA--,651.7531999999998,0,189.14285714285717,5.27274875640869,0.3714285714285714,Anticancer
ACP131,--NA--,MTEEY,5,29287362,--NA--,671.7164,0.2,105.96000000000001,4.0500284194946286,-1.42,Anticancer
ACP132,--NA--,SGFAP,5,29287362,--NA--,477.5108,0.2,46.52,5.240009498596191,0.3599999999999999,Anticancer
ACP133,Lunasin,SKWQHQQDSCRKQKQGVNLTPCEKHIMEKIQGRGDDDDDDDDD,43,"25627564, 24508378",--NA--,5043.329700000004,0.023255813953488372,46.29767441860465,4.673495292663574,-1.941860465,Anticancer
ACP134,Lunasin,SKWQHQQDSCRKQLQGVNLTPCEKHIMEKIQGRGDDDDDDDDN,43,29679803,--NA--,5027.330200000004,0.023255813953488372,48.38139534883721,4.561920356750489,-1.762790698,Anticancer
ACP135,--NA--,WTP,3,29287362,--NA--,402.4443,0.33333333333333337,-43.43333333,5.525000190734862,-1.066666667,Anticancer
ACP136,--NA--,XMLPSYSPY,9,24508378,--NA--,957.1003000000001,0.25,111.82500000000002,5.2745676040649405,-0.2125,Anticancer
ACP137,Viphi G,GSIPCEGSCVFIPCISAIIGCSCSNKVCYKN,31,"25815333, 21723349","MM96L, HeLa, BGC-823, and HFF-1",3196.7822000000006,0.06451612903225806,26.45483870967742,7.769003486633301,0.7258064516129034,Anticancer
ACP138,Lunatusin,KTCENLADTFRGPCFATSNC,20,16269344,"F. oxysporum (IC50=1.9 ?M), B. Cinerea (IC50=2.6 ?M), M. arachidicola(IC50=0.32 ?M), Mycobacterium phlei(IC50=96 ? 9 ?M), Proteus vulgaris(IC50=81 ? 6 ?M), Breast cancer cells(IC50=5.71 ?M), HIV-1 reverse transcriptase(IC50=120 ?M)",2178.4251,0.1,-5.545,6.048885154724121,-0.34,Anticancer
ACP139,Viba 17,GLPVCGETCVGGTCNTPGCGCSWPVCTRN,29,"25815333, 21723349","HFF1, MM96L, HeLa, BGC-823, and HFF-1",2872.2844000000005,0.034482758620689655,35.348275862068974,5.962319374084472,0.16206896551724134,Anticancer
ACP140,Psyle A,GIACGESCVFLGCFIPGCSCKSKVCYFN,28,"20564026, 20575512","MCF-7 (IC50=7.77M), MCF-7/ADR (IC50=>10M), Human histiocytic lymphoma U-937/GTB(IC50: 26 ?M)",2936.4935000000005,0.14285714285714285,43.02142857142858,7.769003486633301,0.8821428571428572,Anticancer
ACP141,psyle E,GVIPCGESCVFIPCISSVLGCSCKNKVCYRD,31,"20564026, 20575512","MCF-7 (IC50=0.64M), MCF-7/ADR (IC50=1.73M); Human histiocytic lymphoma U-937/GTB(IC50: 0.76 ?M)",3280.9019000000003,0.06451612903225806,30.993548387096784,7.769515037536622,0.6516129032258063,Anticancer
ACP142,Varv-F,GVPICGETCTLGTCYTAGCSCSWPVCTRN,29,"20580652, 25815333, 10075760, 12477048","Human Myeloma cells RPMI-8226/s (IC50: 5.90 ?M),Human Myeloma cells RPMI-8226/Dox40 (IC50: 3.14 ?M),Human Myeloma cells RPMI-8226/LR-5 (IC50: 6.31 ?M),Human histiocytic lymphoma U-937/GTB (IC50: 7.07 ?M),Human histiocytic lymphoma U-937-Vcr (IC50: 7.45 ?M),Human renal adenocarcinoma ACHN (IC50: 2.63 ?M),Human lymphoblastic leukemia CCRF-CEM (IC50: 7.13 ?M),Human lymphoblastic leukemia CCRF-CEM/VM-1 (IC50: 7.15 ?M),Human lung carcinoma NCI-H69 (IC50: 7.49 ?M),Human lung carcinoma NCI-H69AR (IC50: 7.12 ?M),Human glioblastoma U251-MG (IC50: 44.49 ?g/ml),Human breast adenocarcinoma MDA-MB-231 (IC50: >10 ?g/ml),Human lung carcinoma A549 (IC50: >10 ?g/ml),Human prostate cancer DU145 (IC50: >10 ?g/ml),Human hepatocarcinoma BEL-7402 (IC50: >10 ?g/ml)",2983.4228999999996,0.06896551724137931,52.46206896551725,5.9617509841918945,0.34137931034482755,Anticancer
ACP143,Phoratoxins D,KSCCPTTTARNIYNTCRFGGGSRPICAKLSGCKIISGTKCD,41,"25815333, 12613665",10 cancer cell lines,4313.018,0.04878048780487805,47.96097560975608,9.33839054107666,-0.234146341,Anticancer
ACP144,Phoratoxins F,KSCCPTTTARNIYNTCRLAGGSRPICAKLSGCKIISGTKCDSGWDH,46,"25815333, 12613665",10 cancer cell lines (IC50= 0.40 ?M),4875.5936,0.043478260869565216,48.02173913043477,9.125580406188966,-0.330434783,Anticancer
ACP145,Lunasin,QLQGVNLTPCEK,12,18211015,--NA--,1329.5221000000001,0,30.050000000000004,5.994262886047363,-0.525,Anticancer
ACP146,Lunasin,WQHQQDSCR,9,18211015,--NA--,1187.2454,0.1111111111111111,109.31111111111112,6.735329627990722,-2.322222222,Anticancer
ACP147,Lunasin,WQHQQDSCRK,10,18211015,--NA--,1315.4177,0.1,99.38,8.230952644348147,-2.48,Anticancer
ACP148,Viscotoxin B2,KSCCKNTTGRNIYNTCRFAGGSRERCAKLSGCKIISASTCPSDYPK,46,25815333,Rat sarcoma cells(IC50=1600 ?M),4977.6855,0.06521739130434782,37.80217391304348,9.455851936340334,-0.641304348,Anticancer
ACP149,"Viscotoxins 1-PS, A1, A2, A3, and B",KSCCPNTTGRNIYNTCRFGGGSREVCARISGCKIISASTCPSDYPK,46,"4417993, 25815333",Human lymphocytes,4903.5605,0.06521739130434782,46.517391304347825,9.12519359588623,-0.447826087,Anticancer
ACP150,Aspartic acid-reach plypeptide Lunasin,SKWQHQQDSCRKQLQGVNLTPCEKHIMEKIQGRGDDDDDDDDD,43,"doi.org/10.1016/j.foodchem.2008.09.023, 3611081",--NA--,5028.315000000004,0.023255813953488372,48.38139534883721,4.503546714782716,-1.762790698,Anticancer
ACP151,Oryzatensin,GYPMYPLPR,9,"11179594, 29287362, 7804141",--NA--,1093.2979,0.2222222222222222,57.83333333333334,8.58971920013428,-0.733333333,Anticancer
ACP152,Viscotoxin C1,KSCCPNTTGRNIYNTCRFAGGSRERCAKLSGCKIISASTCPSDYPK,46,"25815333, 14580196",Rat sarcoma cells,4946.6284,0.06521739130434782,41.9891304347826,9.30254611968994,-0.591304348,Anticancer
ACP153,Varv-A,GLPVCGETCVGGTCNTPGCSCSWPVCTRN,29,"15328347, 16872274, 20580652, 26399495, 18618891, 18081258, 12477048, 14987049, 18191970, 9548831","U251 cell line(IC50=37.18g/mL), Haemonchus contortus and Trichostrongylus colubriformis",2902.3104000000003,0.034482758620689655,46.5896551724138,5.962319374084472,0.14827586206896542,Anticancer
ACP154,Viscotoxin-B (Viscotoxin-B2) (VtB),KSCCPNTTGRNIYNTCRLGGGSRERCASLSGCKIISASTCPSDYPK,46,"5568678, 1710983, 12733989","Fungi: Fusarium solani, Sclerotinia sclerotiorum, Phytophtora infestans.",4857.4906,0.043478260869565216,46.517391304347825,9.12519359588623,-0.55,Anticancer
ACP155,Sequence 1 from Patent US 7071293,KNLRRIIRKIIHIIKKYG,18,US 7071293 B1,"Antimicrobial, Antiproliferative",2262.831200000001,0.05555555555555555,69.08333333333334,11.754278755187986,-0.372222222,Antiproliferative
ACP156,Sequence 2 from Patent US 7071293,RGLRRLGRKIAHGVKKYGPTVLRIIRIAG,29,US 7071293 B1,"Antimicrobial, Antiproliferative",3255.9555,0.034482758620689655,26.41034482758621,11.999967765808105,-0.210344828,Antiproliferative
ACP157,Sequence 7 from Patent US 7071293,KNIRRIIRKIIHIIKKYG,18,US 7071293 B1,"Antimicrobial, Antiproliferative",2262.831200000001,0.05555555555555555,82.79444444444444,11.754278755187986,-0.333333333,Antiproliferative
ACP158,Sequence 8 from Patent US 7071293,LRRIIRKIIHIIKK,14,US 7071293 B1,"Antimicrobial, Antiproliferative",1800.3318000000002,0,92.02857142857145,11.999967765808105,0.17142857142857135,Antiproliferative
ACP159,Sequence 12 from Patent US 7071293,IRRIIRKIIHIIKK,14,US 7071293 B1,"Antimicrobial, Antiproliferative",1800.3318000000002,0,78.27142857142857,11.999967765808105,0.2214285714285713,Antiproliferative
ACP160,Sequence 14 from Patent US 7071293,GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,37,US 7071293 B1,"Antimicrobial, Antiproliferative",4433.388400000002,0.05405405405405405,30.997297297297315,11.537536048889162,-1.097297297,Antiproliferative
ACP161,Sequence 18 from Patent US 7071293,RGLRRLGRKIAHGVKKYGPTVLRIIRIA,28,US 7071293 B1,"Antimicrobial, Antiproliferative",3198.9042,0.03571428571428572,26.996428571428574,11.999967765808105,-0.203571429,Antiproliferative
ACP162,Sequence 27 from Patent US 7071293,NLRRIIRKIIHIIKKY,16,US 7071293 B1,"Antimicrobial, Antiproliferative",2077.6076000000007,0.0625,81.775,11.744350624084472,-0.15,Antiproliferative
ACP163,Sequence 30 from Patent US 7071293,NIRRIIRKIIHIIKKY,16,US 7071293 B1,"Antimicrobial, Antiproliferative",2077.6076000000007,0.0625,97.19999999999999,11.744350624084472,-0.10625,Antiproliferative
ACP164,Sequence 31 from Patent US 7071293,KWKSFIKKLTTAVKKVLTTGLPALIS,26,US 7071293 B1,"Antimicrobial, Antiproliferative",2872.5329,0.07692307692307693,10.261538461538462,10.699318122863769,0.3192307692307691,Antiproliferative
ACP165,Sequence 1 from Patent US 6906035,KWKSFIKKLTSAAKKVVTTAKPLISS,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2861.4673000000003,0.07692307692307693,1.0615384615384622,10.778420829772951,-0.073076923,Antiproliferative
ACP166,Sequence 2 from Patent US 6906035,KWKSFIKNLTKGGSKILTTGLPALIS,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2802.3569,0.07692307692307693,23.52307692307693,10.602486610412598,0.08076923076923065,Antiproliferative
ACP167,Sequence 3 from Patent US 6906035,KWKKFIKNLTKGGSKILTTGLPALIS,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2843.4519,0.07692307692307693,23.52307692307693,10.699318122863769,-0.038461538,Antiproliferative
ACP168,Sequence 4 from Patent US 6906035,KWKSFIKNLEKVLKPGGLLSNIVTSL,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2913.4985,0.07692307692307693,12.034615384615382,10.176866340637208,0.10769230769230773,Antiproliferative
ACP169,Sequence 5 from Patent US 6906035,KWKSFIKNLEKVLKKGPILANLVSIV,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2966.6472,0.07692307692307693,0.6961538461538463,10.301548194885253,0.28846153846153844,Antiproliferative
ACP170,Sequence 6 from Patent US 6906035,KWKEFIKKLTTAVKKVLTTGLPALIS,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2914.5696000000003,0.07692307692307693,10.261538461538462,10.301548194885253,0.2153846153846155,Antiproliferative
ACP171,Sequence 7 from Patent US 6906035,KWKKFIKELQKVLAPGGLLSNIVTSL,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2911.5257000000006,0.07692307692307693,38.14615384615385,10.176866340637208,0.2076923076923076,Antiproliferative
ACP172,Sequence 8 from Patent US 6906035,KWKSFIKKLTSVLKKVVTTALPALIS,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2900.586,0.07692307692307693,8.103846153846154,10.699318122863769,0.49230769230769234,Antiproliferative
ACP173,Sequence 9 from Patent US 6906035,KWKSFIKNLTKVLKKVVTTALPALIS,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2927.6112999999996,0.07692307692307693,8.103846153846154,10.699318122863769,0.38846153846153836,Antiproliferative
ACP174,Sequence 10 from Patent US 6906035,KWKLFKKKGTGAVLTVLTTGLPALIS,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2771.3859000000007,0.07692307692307693,-0.942307692,10.602486610412598,0.44230769230769224,Antiproliferative
ACP175,Sequence 11 from Patent US 6906035,KWKSFIKKLTSVLKKVVTTAKPLISS,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2931.6001,0.07692307692307693,-2.203846154,10.778420829772951,0.09615384615384619,Antiproliferative
ACP176,Sequence 12 from Patent US 6906035,KKKSFIKLLTSAKVSVLTTAKPLISS,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2789.3997000000004,0.038461538461538464,4.3269230769230775,10.699318122863769,0.3038461538461538,Antiproliferative
ACP177,Sequence 13 from Patent US 6906035,KWKKFIKELQKVLKPGGLLSNIVTSL,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2968.620100000001,0.07692307692307693,24.573076923076922,10.301548194885253,-0.011538462,Antiproliferative
ACP178,Sequence 14 from Patent US 6906035,KKWWRRVLSGLKTGPALSNV,20,US 6906035 B2,"Antimicrobial, Antiproliferative",2296.715,0.1,39.28,11.999967765808105,-0.455,Antiproliferative
ACP179,Sequence 15 from Patent US 6906035,KKWWRRVLKGLSSGPALSNV,20,US 6906035 B2,"Antimicrobial, Antiproliferative",2282.6884,0.1,48.910000000000004,11.999967765808105,-0.46,Antiproliferative
ACP180,Sequence 16 from Patent US 6906035,KKWWRRALQALKNGPALSNV,20,US 6906035 B2,"Antimicrobial, Antiproliferative",2336.7391,0.1,52.31,11.999967765808105,-0.74,Antiproliferative
ACP181,Sequence 17 from Patent US 6906035,KKWWRRVLSGLKTAGPAIQSVLNK,24,US 6906035 B2,"Antimicrobial, Antiproliferative",2737.2520000000004,0.08333333333333334,66.11250000000001,11.999967765808105,-0.425,Antiproliferative
ACP182,Sequence 18 from Patent US 6906035,KKWWRRALQGLKTAGPAIQSVLNK,24,US 6906035 B2,"Antimicrobial, Antiproliferative",2750.2508000000003,0.08333333333333334,79.69583333333334,11.999967765808105,-0.6375,Antiproliferative
ACP183,Sequence 19 from Patent US 6906035,KKWWKAQKAVNSGPNALQTLAQ,22,US 6906035 B2,"Antimicrobial, Antiproliferative",2467.822599999999,0.09090909090909091,24.363636363636363,10.477740287780762,-0.881818182,Antiproliferative
ACP184,Sequence 20 from Patent US 6906035,KKWWKAKKFANSGPNALQTLAQ,22,US 6906035 B2,"Antimicrobial, Antiproliferative",2515.9084999999995,0.13636363636363635,24.363636363636363,10.602486610412598,-0.963636364,Antiproliferative
ACP185,Sequence 21 from Patent US 6906035,KKWWKFIKKAVNSGTTGLQTLAS,23,US 6906035 B2,"Antimicrobial, Antiproliferative",2593.0307,0.13043478260869565,12.665217391304349,10.602486610412598,-0.439130435,Antiproliferative
ACP186,Sequence 22 from Patent US 6906035,KKSFFKKLTSVASSVLS,17,US 6906035 B2,"Antimicrobial, Antiproliferative",1857.1976,0.11764705882352942,6.905882352941178,10.477740287780762,0.18235294117647052,Antiproliferative
ACP187,Sequence 23 from Patent US 6906035,WKVFKSFIKKASSFAQSVLD,20,US 6906035 B2,"Antimicrobial, Antiproliferative",2316.6946,0.2,25.095,10.00138339996338,0.1,Antiproliferative
ACP188,Sequence 24 from Patent US 6906035,KWKSFIKK,8,US 6906035 B2,"Antimicrobial, Antiproliferative",1064.3231,0.25,-1.8625,10.477740287780762,-1.25,Antiproliferative
ACP189,Sequence 34 from Patent US 6906035,KKWWRRXXXGLKTAGPAIQSVLNK,21,US 6906035 B2,"Antimicrobial, Antiproliferative",2437.8861,0.09523809523809523,70.08571428571429,11.999967765808105,-0.828571429,Antiproliferative
ACP190,Sequence 35 from Patent US 6906035,KWKLFKKIGIGAVLKVLTTGLPALIS,26,US 6906035 B2,"Antimicrobial, Antiproliferative",2795.4933000000005,0.07692307692307693,-4.207692308,10.602486610412598,0.8423076923076922,Antiproliferative
ACP191,Sequence 36 from Patent US 6906035,KWKLFKKIGIGAVLKVLTTGLPALKKTK,28,US 6906035 B2,"Antimicrobial, Antiproliferative",3080.879200000001,0.07142857142857144,-6.225,10.845339012145995,0.2071428571428571,Antiproliferative
ACP192,Sequence 37 from Patent US 6906035,FFSLIPSLVGGLISAFK,17,US 6906035 B2,"Antimicrobial, Antiproliferative",1796.1556000000005,0.17647058823529413,12.47058823529412,8.750052070617677,1.5352941176470591,Antiproliferative
ACP193,Stigmurin,FFSLIPKLVKGLISAFK,17,29670004,"Antimicrobial, Antibacterial, Anti-Gram+, Antifungal, Antiparasitic, Antiproliferative",1908.3716,0.17647058823529413,-12.80588235,10.302063941955566,1.1470588235294117,Antiproliferative
ACP194,StigA6,FFKLIPKLVKGLISAFK,17,29670004,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiparasitic, Antiproliferative",1949.4665999999997,0.17647058823529413,-26.64117647,10.477740287780762,0.9647058823529413,Antiproliferative
